鶹ýӰ

Gastroenterology

General Hepatology

More in General Hepatology

Prompt Diagnosis, Management of Primary Biliary Cholangitis Key to Quality of Life

Fatigue seems to have the biggest negative impact on patients' quality of life, experts say

4 Hrs Ago
A computer rendering of a transparent body with the biliary tree highlighted.
Randy Moss' Rare GI Cancer: Here's What to Know

Hall of Fame football player recently revealed his cholangiocarcinoma diagnosis

Dec 20, 2024
 A photo of Randy Moss.
Randy Moss Has Cancer; Nancy Pelosi's Surgery; Possible Bird Flu Case Hospitalized

Health news and commentary gathered by MedPage Today staff

Dec 16, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
FDA Issues Safety Alert on Liver Disease Drug

Obeticholic acid (Ocaliva) may cause serious liver damage even in PBC patients without cirrhosis

Dec 12, 2024
FDA SAFETY obeticholic acid (Ocaliva) over a photo of the product over a computer rendering of the biliary tree.
RNA Interference Therapeutic Shows Promise for Chronic Hepatitis B

23% achieved HBsAg loss with xalnesiran plus immunomodulator, but relapses occurred in some

Dec 04, 2024
 A computer rendering of hepatitis B viruses.
Serious Outcomes of Steatotic Liver Disease Hit Men and Women Differently

Liver cancer risk higher among men, while cirrhosis more common in women

Dec 04, 2024
A computer rendering of a transparent female body with a fatty liver highlighted.
Many Drinkers Cut Back After Starting Obesity Meds, Study Finds

In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug

Nov 26, 2024
Pouring whisky away down the sink.
FDA Approves Zanidatamab for Biliary Tract Cancer

New antibody indicated for previously treated, unresectable or metastatic HER2-positive disease

Nov 21, 2024
FDA APPROVED zanidatamab (Ziihera) over a computer rendering of the gall bladder.
Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH

Liver fat reductions were sustained for up to a year with the thyroid hormone receptor agonist

Nov 21, 2024
AASLD over a photo of San Diego Convention Center in San Diego, CA.
'A Watershed Moment': GLP-1 Drug Succeeds in Late-Stage MASH Trial

First positive phase III study for a GLP-1 agonist in chronic liver disease

Nov 20, 2024
AASLD over a photo of San Diego Convention Center in San Diego, CA.
Tapered Steroid Dosing Safe, Effective in Severe Alcohol-Associated Hepatitis

Notably, tapering reduced the risk of infection compared with a fixed dose

Nov 20, 2024
AASLD over a photo of San Diego Convention Center in San Diego, CA.
New MELD Model Improves Access to Liver Transplant for Women

A greater proportion of women on the waitlist and undergoing transplant since adoption

Nov 19, 2024
AASLD over a photo of San Diego Convention Center in San Diego, CA.
Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to Transplant

78% of patients in prospective study had tumor downstaging with immune checkpoint inhibitors

Nov 19, 2024
AASLD over a photo of San Diego Convention Center in San Diego, CA.
Fecal Therapy Shows Survival Benefit in Severe Alcoholic Hepatitis

Improved markers of disease severity as well in small trial of steroid-ineligible patients

Nov 18, 2024
AASLD over a photo of San Diego Convention Center in San Diego, CA.
More in General Hepatology